EUVIMEDEUVIMED entdecken
Crossref

Cardiac Myxomas: A single center experience and ten-years follow up

Essam Elbadry Hashim Mohamed, Ayman Mohamed Mohamed Abdel Ghaffar, Khaled Mohamed Abdelaal, Abdelrahman Adel Abdelaziz Elsayed, Mohamed AW Ezzat, Ahmed Roshdi Hamed Ahmed

The Egyptian Cardiothoracic Surgeon · 2019

DOI: 10.35810/ects.v1i2.54 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Cardiothoracic Surgeon, 2019. Verfasst von Essam Elbadry Hashim Mohamed und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac myxoma is a benign tumor that carries the risk of embolization and obstruction of the blood flow. The ideal surgical approach is still debatable. We present our experience in the surgical treatment of cardiac myxomas and its ideal surgical approach.

Methods

We retrospectively analyzed the data for all patients who underwent surgical excision of cardiac myxoma at our institution over 11 years starting from January 2006 to December 2016. Descriptive statistics were used to present preoperative, operative and postoperative data and Kaplan Meier curve to plot long-term survival.

Results

Twenty-one patients had surgical excision of a primary, single and sporadic cardiac myxoma. Thirteen patients (62 %) were females, and the mean age at operation was 55.2 years (range: 28 – 71 years). The location of myxomas was in the left atrium in 17 patients (81%) and right atrium in 4 patients (19 %). Dyspnea was the main presenting symptom (71.4%) followed by constitutional symptoms (28%), palpitations (23.8%), syncope (14.2%) and stroke (14.2%). A right atrial trans-septal incision was used in 76.5% of left atrial myxoma cases. Five patients had concomitant operative procedures (coronary artery bypass grafting (n=2), tricuspid valve repair (n=1), mitral valve replacement (n=1) and bullectomy (n=1)). Postoperative complications were reported in six patients (28.6%) (supraventricular arrhythmia (n=2), temporary conduction deficit (n=2), pulmonary atelectasis (n=1), and postoperative bleeding (n=1)). Early postoperative mortality occurred in one patient (4.76 %), and there were no late deaths related to myxoma.

Conclusion

Surgical treatment of cardiac myxoma is safe with low morbidity and mortality. The right atrial trans-septal incision is the recommended surgical approach.

Zitieren

APA

Mohamed, E. E. H., Ghaffar, A. M. M. A., Abdelaal, K. M., Elsayed, A. A. A., Ezzat, M. A., & Ahmed, A. R. H. (2019). Cardiac Myxomas: A single center experience and ten-years follow up. The Egyptian Cardiothoracic Surgeon. https://doi.org/10.35810/ects.v1i2.54

Vancouver

Mohamed EEH, Ghaffar AMMA, Abdelaal KM, Elsayed AAA, Ezzat MA, Ahmed ARH. Cardiac Myxomas: A single center experience and ten-years follow up. The Egyptian Cardiothoracic Surgeon. 2019. doi:10.35810/ects.v1i2.54

BibTeX
@article{Mohamed2019,
  author = {Mohamed, Essam Elbadry Hashim and Ghaffar, Ayman Mohamed Mohamed Abdel and Abdelaal, Khaled Mohamed and Elsayed, Abdelrahman Adel Abdelaziz and Ezzat, Mohamed AW and Ahmed, Ahmed Roshdi Hamed},
  title = {Cardiac Myxomas: A single center experience and ten-years follow up},
  journal = {The Egyptian Cardiothoracic Surgeon},
  year = {2019},
  doi = {10.35810/ects.v1i2.54}
}
Kostenlos starten →